A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Drug | Herb or constituent (dose) | Nature of Interaction | Reference | Recommendation | Study type | Population | Sample size | Duration | Single/ multi drug dose | Pharmaco- kinetic only? | Herb product and/or extract | Other notes | |||||||||||||||
2 | 5-Fluorouracil | Withania somnifera root extract (2 g tid) | Decreased fatigue vs. no treatment | Biswal 2013 | Beneficial to combine | ONR | Malaysian women with breast cancer | 100 | 18 weeks | Multi | No | Himalaya Drug Company, New Dehli, India | ||||||||||||||||
3 | 5-Fluorouracil + oxaliplatin + folinic acid (FOLFOX) | Curcumin (2000 mg qd) | Safe to combine, some preliminary indication of improved efficacy | James 2015 | Beneficial to combine | ONR | British adults with metastatic colon cancer | 12 | 24 weeks | Multi | No | |||||||||||||||||
4 | 5-Fluorouracil + oxaliplatin + folinic acid (FOLFOX), some + bevacizumab | Curcumin (2000 mg qd) | Safe to combine, some preliminary indication of improved efficacy | Howells 2019 | Beneficial to combine | ORN | British adults with metastatic colon cancer | 27 | 113 days (mean) | Multi | No | Curcumin C3 Complex, Sabinsa Corporation, Piscataway, NJ (containing ∼80% curcumin and 20% demethoxycurcumin and bisdemethoxycurcumin) | Four patients in control group and 8 patients in curcumin group also got bevacizumab treatment (see separate entry) | |||||||||||||||
5 | Acetaminophen (paracetamol) | Andrographis paniculata extract (520 mg with 30 mg andrographolides tid) | Reduces risk of progression of disease, duration of disease, speeds virus clearance, reduces days of hospitalization, and accelerates symptomatic recovery significantly, when combined with acetaminophen, vs. placebo. | Ratiani 2022 | Beneficial to combine | DBPCR | Georgian adults with mild CoVid-19 | 86 | 14 days | Multi | No | Kan Jang/Nergocov, Swedish Herbal Institute | ||||||||||||||||
6 | Acetaminophen (paracetamol) | Curcuminoids (4 g) + piperine (24 mg) | No interaction | Volak 2013 | Fine to combine without dose adjustments | OPRCX | Healthy American adults (6 White, 1 Black, 1 Arab) | 8 | 1 day | Single | Yes | Sabinsa Corporation, Piscataway, NJ | ||||||||||||||||
7 | Acetaminophen (paracetamol) | Eleutherococcus senticosus root extract (37 mg tid) | Reduces risk of progression of disease, duration of disease, speeds virus clearance, reduces days of hospitalization, and accelerates symptomatic recovery significantly, when combined with acetaminophen, vs. placebo. | Ratiani 2022 | Beneficial to combine | DBPCR | Georgian adults with mild CoVid-19 | 86 | 14 days | Multi | No | Kan Jang/Nergocov, Swedish Herbal Institute | ||||||||||||||||
8 | Alprazolam | Eleutherococcus senticosus root extract (485 mg bid) | No interaction | Donovan 2003 | Fine to combine without dose adjustments | ONR | Healthy American adults | 12 | 12 days | Single | Yes | CYP3A4 probe drug | ||||||||||||||||
9 | Alprazolam | Glycyrrhiza glabra, deglycyrrhizinated or DGL (75 mg bid) | No significant interaction | Liu 2023 | Fine to combine without dose adjustment | ONR | Healthy American women | 19 | 14 days | Multie | Yes | Natural Remedies (Bangalore, India) | CYP3A4 probe drug | |||||||||||||||
10 | Alprazolam | Valeriana officinalis (1 g hs, standardized to 11 mg valerienic acid) | No significant interaction | Donovan 2004 | Fine to combine without dose adjustment | ORN | Healthy American adults | 12 | 14 days | Multie | Yes | Dr. Willmar Schwabe GmbH and Co. (Karlsruhe, Germany) | CYP3A4 probe drug | |||||||||||||||
11 | Ambrisentan | Hypericum perforatum aerial parts extract (300 mg tid) | Slight reduction in absorption, no clinically-relevant interaction (regardless of CYP2C19 genotype) | Markert 2015 | Fine to combine without dose adjustments | ORCX | Healthy German adults | 20 | 20 days | Multi | Yes | Jarsin300 (LI 160), Lichtwer Pharma, Berlin, Germany | CYP2C19 substrate | |||||||||||||||
12 | Amitriptyline | Hypericum perforatum aerial parts extract (900 mg qd) | Significant reduction in serum amitriptyline and metabolites within 3 days, but no obvious interference with antidepressant efficacy | Johne 2001 | Combine cautiously, may require higher amitriptyline dose, monitor carefully | ORN | German adults with depression | 11 | 14–16 days | Multi | No | Jarsin300 (LI 160), Lichtwer Pharma, Berlin, Germany | Note strange once-daily dosing of Hypericum extract. | |||||||||||||||
13 | Amoxicillin | Glycyrrhiza glabra root extract (380 mg bid) | Improved eradication of Helicobacter pylori and resolution of peptic ulcer or dyspepsia | Hajiagha- mohammadi 2016 | Beneficial to combine | ORN | Iranian adults with H. pylori and peptic ulcer or dyspepsia | 108 | 14 days | Multi | No | D-Reglis, Iran Sanduc Pharmacy Company | ||||||||||||||||
14 | Amoxicillin | Glycyrrhiza glabra root extract (500 mg tid) | Improved eradication of Helicobacter pylori and resolution of peptic ulcer | Rahnama 2013 | Beneficial to combine | DBACR | Iranian adults with H. pylori and peptic ulcer | 40 | 30 days | Multi | No | Not stated | ||||||||||||||||
15 | Antibiotics (multiple), decongestant | Sambucus nigra (elder) flowers 2 parts, Verbena officinalis (vervain) herb 2 parts, Rumex acetosa (sour dock) herb 2 parts, Primula veris (cowslip) flowers 2 parts, Gentiana lutea (gentian) 1 part | Herbal formula + drugs led to much better symptomatic and radiographic improvement compared to placebo + drugs. | Neubauer 1994 | Beneficial to combine | DBPCR | German adults with acute bacterial sinusitis | 160 | Multi | No | Sinupret, Bionorica, Neumarkt, Germany | |||||||||||||||||
16 | Apixaban | artemisinin (>100 mg qd) | Apixaban absorption reduced | May require apixaban dose increaes | Theory | This is a likely interaction based on apixaban being a CYP3A4 substrate and artemisinin inducing this enzymes in the intestines. Use of whole Artemisia annua, except at very high doses, is unlikely to be a problem. | ||||||||||||||||||||||
17 | Aspirin | Allium sativum bulb powder tablet (400 mg w/ 1.2 mg allicin bid) | No interaction | Mahdavi-Roshan 2016 | Fine to combine without dose adjustments | DBPCR | Iranian adults with severe coronary artery disease | 56 | 12 weeks | Multi | No | Not stated | Patients were also all taking clopidogrel and atorvastatin | |||||||||||||||
18 | Aspirin | Angelica sinensis root extract (~1 g tid) | Signifcant reduction in cardiac mortality, nonfatal recurrent MI, ischemia-drive revascularization, stroke, or CHF; significant but slight improvment in eGFR | Zhang 2020b | Beneficial to combine | ORN | Chinese adults recovering from myocardial infarction (s/p angioplasty) and CKD G2–3b | 426 | 6 mon | Multi | No | Fufang Chuanng Capsule (Shandong Phoenix Pharmaceutical Co., Ltd., Dongying City, Shandong Province, China) | ||||||||||||||||
19 | Aspirin | Angelica sinensis root extract (1 g qd) | No interaction. Two volunteers reported heavier menses while taking dong quai, but this could have due to hormonal effects of herbs (there was no sign of changes in any coagulation parameters in either woman). | Fung 2017 | Fine to combine without dose adjustments | DBPCR | Healthy Chinese adults | 25 | 3 weeks | Multi | No | GNC Herbal Plus Turmeric Curcumin by Nutra Manufacturing (Pittsburgh, PA, USA) | Aspirin 100 mg per day | |||||||||||||||
20 | Aspirin | Curcumin (500 mg qd) | No interaction | Fung 2017 | Fine to combine without dose adjustments | DBPCR | Healthy Chinese adults | 25 | 3 weeks | Multi | No | GNC Ginseng Gold Korean White Ginseng Root by Nutra Manufacturing (Pittsburgh, PA, USA) | Aspirin 100 mg per day | |||||||||||||||
21 | Aspirin | Curcumin phosholipid complex (1 g qd) | No interaction | Hu 2018 | Fine to combine without dose adjustments | ONR (?) | Italian adults with cardiovascular disease | 18 | 10 days | Multi | No | Meriva, Indena SpA, Milan, Italy | The methodology used (in terms of whether or not subjects were randomly assigned to active drug alone or drug + curcumin-phospholipid complex, whether there was any blinding) was not described | |||||||||||||||
22 | Aspirin | Ginkgo biloba extract | see separate review in the Articles section (Ginkgo and Anticoagulants) | Fine to combine without dose adjustments | ||||||||||||||||||||||||
23 | Aspirin | Ligusticum chuanxiong root (~1 g tid) | Signifcant reduction in cardiac mortality, nonfatal recurrent MI, ischemia-drive revascularization, stroke, or CHF; significant but slight improvment in eGFR | Zhang 2020b | Beneficial to combine | ORN | Chinese adults recovering from myocardial infarction (s/p angioplasty) and CKD G2–3b | 426 | 6 mon | Multi | No | Fufang Chuanng Capsule (Shandong Phoenix Pharmaceutical Co., Ltd., Dongying City, Shandong Province, China) | ||||||||||||||||
24 | Aspirin | Panax ginseng root extract (1 g qd) | No interaction | Fung 2017 | Fine to combine without dose adjustments | DBPCR | Healthy Chinese adults | 25 | 3 weeks | Multi | No | GNC Herbal Plus ® Fingerprinted Dong Quai by Nutra Manufacturing (Pittsburgh, PA, USA) | Aspirin 100 mg per day | |||||||||||||||
25 | Aspirin | Panax notoginseng root extract (100 mg tid) | Improved neurological recovery with no changes in blood clotting or any other adverse effects | He 2011 | Beneficial to combine | DBPCR | Chinese adults recovering from ischemic strokes | 140 | 30 days | Multi | No | Note use of low-dose aspirin (50 mg) | ||||||||||||||||
26 | Aspirin | Panax quinquefolius leaf/stem (~1 g tid) | Signifcant reduction in cardiac mortality, nonfatal recurrent MI, ischemia-drive revascularization, stroke, or CHF; significant but slight improvment in eGFR | Zhang 2020b | Beneficial to combine | ORN | Chinese adults recovering from myocardial infarction (s/p angioplasty) and CKD G2–3b | 426 | 6 mon | Multi | No | Xinyue Capsule (Jilin Jian Yisheng Pharmaceutical Co., Ltd., Jian City, Jilin Province, China) | ||||||||||||||||
27 | Aspirin | Phyllanthus emblica extract (500 mg bid) | No interaction | Fatima 2014 | Fine to combine without dose adjustments | ORCX | Indian adults with type 2 diabetes mellitus | 10 | 14 days | Multi | No | Capros, Natreon, New Brunswick, NJ (standardized to 60% low molecular weight hydrolyzable tannins) | Phyllanthus emblica (amla) extract by itself did induce significant anticoagulation, combined with 75 mg aspirin the level of anticoagulation was no different than aspirin alone. There were no spontaneous bleeding events. | |||||||||||||||
28 | Aspirin | Pueraria montana ssp lobata root granulation (225 mg bid) | mild synergistic effects, mild increase in aspirin systemic exposure, no increase in GI or other bleeding | Zhang 2020a | Beneficial to combine | ONRCX | Healthy Chinese men | 14 | 5 days | Multi | No | Nong's Concentrate Chinese Medicine Granules, PuraPharm Internatinoal Limited (Hong Kong) | ||||||||||||||||
29 | Aspirin | Quercetin phytosome (100 mg bid) | No change in bleeding time | Riva 2019 | Fine to combine without dose adjustments | ONR | Italian adults requiring antiplatelet therapy | 10 | 10 days | Multi | No | |||||||||||||||||
30 | Aspirin | Salvia miltiorrhiza root granulation (525 mg bid) | mild synergistic effects, mild increase in aspirin systemic exposure, no increase in GI or other bleeding | Zhang 2020a | Beneficial to combine | ONRCX | Healthy Chinese men | 14 | 5 days | Multi | No | Nong's Concentrate Chinese Medicine Granules, PuraPharm Internatinoal Limited (Hong Kong) | ||||||||||||||||
31 | Atorvastatin | Allium sativum bulb powder tablet (400 mg w/ 1.2 mg allicin bid) | No interaction | Mahdavi-Roshan 2016 | Fine to combine without dose adjustments | DBPCR | Iranian adults with severe coronary artery disease | 56 | 12 weeks | Multi | No | Not stated | Patients were also all taking aspirin and clopidogrel | |||||||||||||||
32 | Atorvastatin | Ginkgo biloba extract (120 mg every 3rd day) | Slight reduction in absorption, no clinically-relevant interaction | Guo 2012 | Fine to combine without dose adjustments | ORCX | Healthy Chinese adults | 16 | 14 days | Single | No | Dr. Willmar Schwabe extract | ||||||||||||||||
33 | Atorvastatin | Hypericum perforatum extract (300 mg bid) | LDL and total cholesterol levels were significantly higher with Hypericum compared to the multivitamin. | Andrén 2007 | Do not combine without increasing atorvastatin dose | ORCX (multivitamin control) | Swedish adults with hypercholesterolemia | 16 | 4 weeks | Multi | No | Movina | Hypericum was underdosed (more usual to give 300 mg tid) | |||||||||||||||
34 | Atorvastatin | Salvia officinalis leaf ethanol extract (500 mg tid) | Lowers LDL and total cholesterol, glucose levels | Kianbakht 2016 | Beneficial to combine | DBPCR | Iranian adults with DM2 and dyslipidemia | 100 | 2 mon | Multi | No | made by the researchers | Absolute magnitude of effect was small (TC 10 point drop, LDL 1 point drop, HDL 1 point gain, HgbA1c 0.2% drop, 2h PPG 5 mg/dl drop compared to baseline (but all significantly better than placebo). | |||||||||||||||
35 | Atorvastatin | silymarin 60–80% 105 mg + Berberis aristata 588 mg providing berberine 500 mg | Allows for 50% statin dose reduction with no loss of efficacy and with additional improvements in glucose control | Derosa 2015 | Beneficial to combine | DBRPC | Italian adults with dyslipidemia not tolerating high-dose statin | 163 | 6 mon | Multi | No | Berberol (PharmaExtract, Pontenure, Italy) | ||||||||||||||||
36 | Azithromycin | Echinacea spp root tincture (5 ml tid) | Reduced frequency and severity of tonsillitis episodes vs. no treatment or azithromycin alone | Awad 2020 | Beneficial to combine | ONR | Egyptian children with recurrent tonsillitis | 300 | 6 days/mon for 6 mon | Multi | No | Not stated | ||||||||||||||||
37 | Bevacizumab | Curcumin (2000 mg qd) | Safe to combine, some indication of improved efficacy | Howells 2019 | Beneficial to combine | ORN | British adults with metastatic colon cancer | 12 | 113 days (mean) | Multi | No | Curcumin C3 Complex, Sabinsa Corporation, Piscataway, NJ (containing ∼80% curcumin and 20% demethoxycurcumin and bisdemethoxycurcumin) | see entry under 5-fluorouracil + oxaliplatin + folinic acid (FOLFOX) for more details | |||||||||||||||
38 | Boceprevir | Hypericum perforatum | No clinically-relevant changes in the drug or its metabolites | Jackson 2014 | Fine to combine without dose adjustments | ORCX | Healthy British adults | 17 | 14 days | Multi | Yes | |||||||||||||||||
39 | Buproprion | Hypericum perforatum extract (325 mg tid) | Mild decrease in buproprion absorption, questionable clinical relevance | Lei 2010 | Likely fine to combine, monitor treatment efficacy | ONR? | Healthy Chinese men | 18 | 14 days | Single | Yes | |||||||||||||||||
40 | Caffeine | Ginkgo biloba extract (120 mg bid or 240 mg qd) | No interaction | Zadoyan 2012 | Fine to combine without dose adjustments | OPRCX | Healthy German adults | 18 | 8 days | Single | Yes | EGb 761 | ||||||||||||||||
41 | Capecitabine | Prunus mume ethanol extract (100 mg qd) | Reduces diarrhea significantly vs placebo | Xing 2018 | Beneficial to combine | PCR | Chinese women with breast cancer | 208 | 6 weeks | Multi | No | |||||||||||||||||
42 | Carbamazepine | Hypericum perforatum extract (300 mg tid) | No interaction | Burstein 2000 | Fine to combine without dose adjustments | ONR | Healthy American adults | 8 | 14 days | Multi | Yes | |||||||||||||||||
43 | Carbamazepine | Piperine (20 mg) | Increased absorption only at carbamazepine 500 mg bid dose, not 300 mg bid (dose sparing) | Pattanaik 2009 | Combine cautiously, reduce phenytoin dose, monitor serum levels carefully if combined | ONR (not clearly stated) | Indian adults with epilepsy | 20 | 1 dose | Single | Yes | Synthite Pharma (Kerala, India) | ||||||||||||||||
44 | Chlorpromazine | Silybum marianum extract silymarin (800 mg qd) | Decreased oxidative hepatic damage compared to placebo | Palasciano 1994 | Beneficial to combine | DBPCR | Italian women with schizophrenia | 60 | 3 mon | Multi | No | not stated | ||||||||||||||||
45 | Cilostazol | Ginkgo biloba extract | see separate review in the Articles section (Ginkgo and Anticoagulants) | Fine to combine without dose adjustments | One smaller study found the combination prolonged bleeding times, while a larger study could not confirm this finding. | |||||||||||||||||||||||
46 | Citalopram | Lepidium meyenii (3 g qd) | Reduced sexual side effects. | Dording 2008 | Beneficial to combine | DBR | American adults with low-libido due to SSRI | 16 | 12 weeks | Multi | No | A Healthy Alternative (Long Island, NY) | ||||||||||||||||
47 | Clarithromycin | Glycyrrhiza glabra root extract (380 mg bid) | Improved eradication of Helicobacter pylori and resolution of peptic ulcer or dyspepsia | Hajiagha- mohammadi 2016 | Beneficial to combine | ORN | Iranian adults with H. pylori and peptic ulcer or dyspepsia | 108 | 14 days | Multi | No | D-Reglis, Iran Sanduc Pharmacy Company | ||||||||||||||||
48 | Clonazepam | Curcumin (250–750 mg bid) | No interaction | Kanchanatawan 2018 | Fine to combine without dose adjustments | DBPRC | Depressed Thai adults | 16 | 16 weeks | Multi | No | Government Pharmaceutical Organization (Bangkok, Thailand) | ||||||||||||||||
49 | Clopidogrel | Allium sativum bulb powder tablet (400 mg w/ 1.2 mg allicin bid) | No interaction | Mahdavi-Roshan 2016 | Fine to combine without dose adjustments | DBPCR | Iranian adults with severe coronary artery disease | 56 | 12 weeks | Multi | No | Not stated | Patients were also all taking aspirin and atorvastatin | |||||||||||||||
50 | Clopidogrel | Angelica sinensis root extract (~1 g tid) | Signifcant reduction in cardiac mortality, nonfatal recurrent MI, ischemia-drive revascularization, stroke, or CHF; significant but slight improvment in eGFR | Zhang 2020b | Beneficial to combine | ORN | Chinese adults recovering from myocardial infarction (s/p angioplasty) and CKD G2–3b | 426 | 6 mon | Multi | No | Fufang Chuanng Capsule (Shandong Phoenix Pharmaceutical Co., Ltd., Dongying City, Shandong Province, China) | ||||||||||||||||
51 | Clopidogrel | Citrus x paradisi juice (200 ml tid) | Interferes with activation of clopidogrel | Holmberg 2014 | Do not combine large doses | ORCX | Healthy Finnish adults | 14 | 3 days | Single | No | Valio greippitäysmehu (Valio, Helsinki, Finland) | Note extremely high GFJ dose | |||||||||||||||
52 | Clopidogrel | Curcumin phosholipid complex (1 g qd) | No interaction | Hu 2018 | Fine to combine without dose adjustments | ONR (?) | Italian adults with cardiovascular disease | 10 | 10 days | Multi | No | Meriva, Indena SpA (Milan, Italy) | The methodology used (in terms of whether or not subjects were randomly assigned to active drug alone or drug + curcumin-phospholipid complex, whether there was any blinding) was not described | |||||||||||||||
53 | Clopidogrel | Ginkgo biloba | see separate review in the Articles section (Ginkgo and Anticoagulants) | Fine to combine without dose adjustments | ||||||||||||||||||||||||
54 | Clopidogrel | Hypericum perforatum extract (300 mg tid) | Enhances activity (by increasing activation of this prodrug) in initial non-responders to the drug | Lau 2011 | Beneficial to combine in hyporesponders to clopidogrel | DBRPC | American adults s/p coronary artery stenting, clopidogrel hyporesponders | 20 | 14 days | Multi | No | |||||||||||||||||
55 | Clopidogrel | Hypericum perforatum extract (300 mg tid) | Enhances activity (by increasing activation of this prodrug) in initial non-responders to the drug | Trana 2013 | Beneficial to combine in hyporesponders to clopidogrel | ORN | Belgian adults with stable angina, s/p PCI, clopidogrel hyporesponders | 23 | 14 days | Multi | No | |||||||||||||||||
56 | Clopidogrel | Ligusticum chuanxiong root (~1 g tid) | Signifcant reduction in cardiac mortality, nonfatal recurrent MI, ischemia-drive revascularization, stroke, or CHF; significant but slight improvment in eGFR | Zhang 2020b | Beneficial to combine | ORN | Chinese adults recovering from myocardial infarction (s/p angioplasty) and CKD G2–3b | 426 | 6 mon | Multi | No | Fufang Chuanng Capsule (Shandong Phoenix Pharmaceutical Co., Ltd., Dongying City, Shandong Province, China) | ||||||||||||||||
57 | Clopidogrel | Panax quinquefolius leaf/stem (~1 g tid) | Signifcant reduction in cardiac mortality, nonfatal recurrent MI, ischemia-drive revascularization, stroke, or CHF; significant but slight improvment in eGFR | Zhang 2020b | Beneficial to combine | ORN | Chinese adults recovering from myocardial infarction (s/p angioplasty) and CKD G2–3b | 426 | 6 mon | Multi | No | Xinyue Capsule (Jilin Jian Yisheng Pharmaceutical Co., Ltd., Jian City, Jilin Province, China) | ||||||||||||||||
58 | Clopidogrel | Phyllanthus emblica extract (500 mg bid) | No interaction | Fatima 2014 | Fine to combine without dose adjustments | ORCX | Indian adults with type 2 diabetes mellitus | 10 | 14 days | Multi | No | Capros, Natreon, New Brunswick, NJ (standardized to 60% low molecular weight hydrolyzable tannins) | Phyllanthus emblica (amla) extract by itself did induce significant anticoagulation, combined with 75 mg clopidogrel the level of anticoagulation was no different than clopidogrel alone. There were no spontaneous bleeding events. | |||||||||||||||
59 | Clopidogrel | Quercetin phytosome (100 mg bid) | No change in bleeding time | Riva 2019 | Fine to combine without dose adjustments | ONR | Italian adults requiring antiplatelet therapy | 10 | 10 days | Multi | No | |||||||||||||||||
60 | Clozapine | Withania somnifera root extract (400 mg tid) | Reduced fasting blood glucose and triglyceride levels vs placebo | Agnihotri 2013 | Beneficial to combine | DBRPC | Indian adults with schizophrenia | 30 | 30 days | Multi | No | Cap Strelaxin, M/s Pharmanza Herbal Pvt. Ltd (Gujarat, India) | ||||||||||||||||
61 | Clozapine | Berberis vulgaris root (500 mg tid) | Slightly offset weight gain | Rostami 2023 | Fine to combine without dose adjustments | DBRPC | Iranian adults with schizophrenia | 88 | 3 mon | Multi | No | Crude powder purchased in Khorasan, Iran, encapsulated at Ahvaz Medicinal Plants Research Center | ||||||||||||||||
62 | Corticosteroids | Curcumin nano-micellar extract (160 mg qd) | No interaction | Hassaniazid 2021 | Fine to combine without dose adjustments | DBPCR | Iranian adults with CoVid-19 | 40 (variable) | 14 days | Multi | No | SinaCurcumin, Exir Nano Sina, Tehran, Iran | This was not explicitly designed to assess for interactions, but many patients were taking the drug at the same time as the curcumin. | |||||||||||||||
63 | Cyclosphosphamide | Withania somnifera root extract (2 g tid) | Decreased fatigue vs. no treatment | Biswal 2013 | Beneficial to combine | ONR | Malaysian women with breast cancer | 100 | 18 weeks | Multi | No | Himalaya Drug Company, New Dehli, India | ||||||||||||||||
64 | Cyclosporin | Allium sativum (1 raw clove garlic chewed qd) | Nephroprotective without interfering with cyclosporin | Jabbari 2005 | Beneficial to combine, monitor therapy | ORCX | Iranian adults with kidney transplants | 44 | 60 days | Multi | No | |||||||||||||||||
65 | Cyclosporin | Berberine (200 mg tid) | Signficantly increases absorption of cyclosporin (dose sparing), ~25–30% | Wu 2005 | Beneficial to combine, reduce cyclosporin dose, monitor therapy | ORN | Chinese adults with kidney transplants | 52 | 90 days | Multi | No | Additionally 6 subjects were monitored for 12 days while taking berberine + cyclosporin to look at pharmacokinetic interactions in detail. Mean AUC increased 34.5%, tmax 1.7 h, t1/2 2.7 h | ||||||||||||||||
66 | Cyclosporin | Berberine (300 mg bid) | Signficantly increases absorption of cyclosporin (dose sparing) | Xin 2006 | Beneficial to combine, reduce cyclosporin dose, monitor therapy | ONR | Healthy Chinese men | 6 | 10 days | Single | Yes | |||||||||||||||||
67 | Cyclosporin | Citrus maxima (pomelo) juice (240 ml) | Significantly but mildly increased absorption | Grenier 2006 | Beneficial to combine, reduce cyclosporin dose, monitor therapy | ORCX | Healthy Canadian men | 12 | 1 dose | Single | Yes | |||||||||||||||||
68 | Cyclosporin | Citrus tangerina (tangerine) juice (250 ml) | No interaction | Sorkhi 2008 | Fine to combine without dose adjustments | ORCX | Iranian child kidney transplant recipients | 10 | 1 dose | Single | Yes | |||||||||||||||||
69 | Cyclosporin | Citrus tangerina (tangerine) juice (250 ml) | No interaction | Sorkhi 2007 | Fine to combine without dose adjustments | ORCX | Iranian adult kidney transplant recipients | 10 | 1 dose | Single | Yes | |||||||||||||||||
70 | Cyclosporin | Citrus x sinensis (orange) juice (250 ml) | No interaction | Sorkhi 2009 | Fine to combine without dose adjustments | ORCX | Iranian child kidney transplant recipients | 10 | 1 dose | Single | Yes | |||||||||||||||||
71 | Cyclosporin | Citrus x sinensis (orange) juice (250 ml) | No interaction | Sorkhi 2007 | Fine to combine without dose adjustments | ORCX | Iranian adult kidney transplant recipients | 10 | 1 dose | Single | Yes | |||||||||||||||||
72 | Cyclosporin | Glycyrhizin from Glycyrrhiza spp (5–10 mg/kg qd, a very high dose) | Glyycrrhizin significantly enhanced the efficacy and reduced the toxicity (nausea, vomiting, liver damage) of the drug | Ren 2013 | Beneficial to combine, monitor therapy | ORN | Chinese adults with mild aplastic anemia | 68 | 4 mon | Multi | No | not stated | Directly contradicts animal research that suggested glycyrrhizin would interfere with absorption of cyclosporine (Hou YC, Lin SP, Chao PD (2012) "Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A" Food Chem 135(4):2307–12.) | |||||||||||||||
73 | Cyclosporin | Hypericum perforatum extract (300 mg tid) | Decreased absorption significantly | Dresser 2003 | Do not combine | Healthy American adults | 21 | 12.5 days | Multi | Yes | ||||||||||||||||||
74 | Cyclosporin | Hypericum perforatum extracts (300 mg tid, high or low hyperforin contents) | High-hyperforin (but now low-hyperforin) extracts significantly reduced absorption and required significant dose increases | Mai 2004 | Do not combine (low-hyperforin extract fine to combine) | RC | German kidney transplant recipients | 10 | 14 days | Multi | Yes | |||||||||||||||||
75 | Cyclosporin | Hypericum perforatum extracts (600 mg qd) | Significantly reduced absorption, causing need to increase dose of cyclosporin (60% on average) to maintain therapeutic serum levels | Bauer 2003 | Do not combine | ONR | German kidney transplant recipients | 11 | 14 days | Multi | No | Jarsin300, Lichtwer Pharma, Berlin, Germany | Onset of reduced absorption within 72 hours. Took more than 2 weeks to return to baseline in most patients | |||||||||||||||
76 | Cyclosporin | Silybum marianum extract silibinin (20 mg/kg IV qd) | No interference with drug, lowered HCV viral loads significantly compared to placebo | Rendina 2014 | Beneficial to combine | DBPCR | Italian adults with hepatitis C status-post liver transplant | 20 | 14 days | Multi | No | Legalon Sil, Madaus, Germany | ||||||||||||||||
77 | Cyclosporin | Vaccinium macrocarpon juice (240 ml) | No interaction | Grenier 2006 | Fine to combine without dose adjustments | ORCX | Healthy Canadian men | 12 | 1 dose | Single | Yes | |||||||||||||||||
78 | Dabigatran | Curcumin phosholipid complex (1 g qd) | No interaction | Hu 2018 | Fine to combine without dose adjustments | ONR (?) | Italian adults with cardiovascular disease | 16 | 10 days | Multi | No | Meriva, Indena SpA, Milan, Italy | The methodology used (in terms of whether or not subjects were randomly assigned to active drug alone or drug + curcumin-phospholipid complex, whether there was any blinding) was not described | |||||||||||||||
79 | Dabigatran | Quercetin phytosome (100 mg bid) | No change in INR or platelet count | Riva 2019 | Fine to combine without dose adjustments | ONR | Italian adults requiring anticoagulant therapy | 10 | 20 days | Multi | No | |||||||||||||||||
80 | Darunavir | Echinacea purpurea root extract (500 mg qid) | No interaction | Moltó 2011 | Fine to combine without dose adjustments | ONR | HIV+ Spanish adults | 15 | 14 days | Multi | Yes | Arkocápsulas Echinácea, Arkopharma, Madrid, Spain | ||||||||||||||||
81 | Darunavir | Silymarin (150 mg tid) | No interaction | Moltó 2012b | Fine to combine without dose adjustments | ONR | HIV+ Spanish adults | 15 | 14 days | Multi | Yes | Arkocápsulas Echinácea, Arkopharma, Madrid, Spain | ||||||||||||||||
82 | Desferrioxamine | Silymarin 80% (140 mg tid) | Significantly enhanced its iron-chelating properties compared to placebo. Also significantly lowers serum transaminase levels compared to placebo | Moayedi 2013 | Beneficial to combine | DBPCR | Iranian adults with β-thalassemia major | 97 | 9 mon | Multi | No | |||||||||||||||||
83 | Dextromethorphan | Valeriana officinalis (1 g hs, standardized to 11 mg valerienic acid) | No significant interaction | Donovan 2004 | Fine to combine without dose adjustment | ORN | Healthy American adults | 12 | 14 days | Multie | Yes | Dr. Willmar Schwabe GmbH and Co. (Karlsruhe, Germany) | CYP2D6 probe drug | |||||||||||||||
84 | Dextromethorphan | Eleutherococcus senticosus root extract (485 mg bid) | No interaction | Donovan 2003 | Fine to combine without dose adjustments | ONR | Healthy American adults | 12 | 12 days | Single | Yes | CYP2D6 probe drug | ||||||||||||||||
85 | Dextromethorphan | Ginkgo biloba leaf extract (120 mg bid or 240 mg qd) | No interaction | Zadoyan 2012 | Fine to combine without dose adjustments | OPRCX | Healthy German adults | 18 | 8 days | Single | Yes | EGb 761 | CYP2D6 probe drug | |||||||||||||||
86 | Dextromethorphan | Glycyrrhiza glabra, deglycyrrhizinated or DGL (75 mg bid) | No significant interaction | Liu 2023 | Fine to combine without dose adjustment | ONR | Healthy American women | 19 | 14 days | Multie | Yes | Natural Remedies (Bangalore, India) | CYP2D6 probe drug | |||||||||||||||
87 | Diclofenac | Curcumin + volatile oil of Curcuma longa 500 mg bid | Improved pain control in knee osteoarthritis and reduced adverse effects | Shep 2020 | Beneficial to combine | ORN | Indian adults with knee OA | 140 | 28 days | Multi | No | BCM-95, Arjuna Natural Pvt. Ltd, India | ||||||||||||||||
88 | Digoxin | Actaea racemosa extract 2.5% triterpenoids (20 mg bid) | No interaction | Gurley 2006 | Fine to combine without dose adjustments | ONR | Healthy American adults | 16 | 14 days | Multi | Yes | Enzymatic Therapy, Green Bay, WI | ||||||||||||||||
89 | Digoxin | Echinacea angustifolia root extract (72 mg tid) | No interaction | Gurley 2008 | Fine to combine without dose adjustments | ORN | Healthy American adults, daily cannabis users | 18 | 14 days | Single | Yes | Gaia Herbs, combined with Echinacea purpurea leaf, root and seed 195 mg tid | ||||||||||||||||
90 | Digoxin | Echinacea purpurea leaf, root, seed extract (195 mg tid) | No interaction | Gurley 2008 | Fine to combine without dose adjustments | ORN | Healthy American adults, daily cannabis users | 18 | 14 days | Single | Yes | Gaia Herbs, combined with Echinacea angustifolia root extract 72 mg tid | ||||||||||||||||
91 | Digoxin | Ginkgo biloba extract (80 mg tid) | No interaction | Mauro 2003 | Fine to combine without dose adjustments | ORCX | Healthy American adults | 8 | 14 days | Single | Yes | |||||||||||||||||
92 | Digoxin | Hypericum perforatum (multiple products and extracts) | Only products and extracts with hyperforin significantly reduced absorption of digoxin compard to placebo; clinical effects of the drug not assessed | Mueller 2004 | Do not combine (low-hyperforin extract fine to combine) | PCR | Healthy German adults | 96 | 14 days | Multi | Yes | Ze117 , LI 160, powder, tea, juice, oil | Supports that Hypericum perforatum and specifically hyperforin upregulates Pgp (likely secondary to PXR upregulation). | |||||||||||||||
93 | Digoxin | Hypericum perforatum extract (300 mg tid) | Significantly reduced digoxin absorption | Gurley 2008 | Do not combine (low-hyperforin extract fine to combine) | ORN | Healthy American adults, daily cannabis users | 18 | 14 days | Single | Yes | WS 5572 | ||||||||||||||||
94 | Digoxin | Hypericum perforatum extract (300 mg tid) | After 10 days of SJW use, digoxin absorption was significantly reduced compared to placebo; clinical effects of the drug not assessed | Johne 1999 | Do not combine (low-hyperforin extract fine to combine) | SBPCR | Healthy German adults | 25 | 15 days | Multi | Yes | LI 160 (Kira, Lichtwer Pharma, Berlin, Germany) | Supports that Hypericum perforatum upregulates Pgp (likely secondary to PXR upregulation). | |||||||||||||||
95 | Digoxin | Hypericum perforatum extract (300 mg tid) | Mild decrease in absorption, roughly 18% (not clearly clinically relavant) | Dürr 2000 | Do not combine (low-hyperforin extract fine to combine) | Healthy Swiss men | 8 | 14 days | Single | Yes | Supports that Hypericum induces intestinal P-glycoprotein | |||||||||||||||||
96 | Digoxin | Silybum marianum extract 80% silymarin (300 mg tid) | No significant changes but statistical trend toward lowering absorption | Gurley 2006 | Fine to combine without dose adjustments (monitor serum levels) | ONR | Healthy American adults | 16 | 14 days | Multi | Yes | Enzymatic Therapy, Green Bay, WI | ||||||||||||||||
97 | Diphenhydramine | Curcumin nano-micellar extract (160 mg qd) | No interaction | Hassaniazid 2021 | Fine to combine without dose adjustments | DBPCR | Iranian adults with CoVid-19 | 40 (variable) | 14 days | Multi | No | SinaCurcumin, Exir Nano Sina, Tehran, Iran | This was not explicitly designed to assess for interactions, but many patients were taking the drug at the same time as the curcumin. | |||||||||||||||
98 | Docetaxel | Curcumin (6,000 mg qd for 4 days before and 2 days after drug infusion) | No interaction | Bayet-Robert 2010 | Fine to combine without dose adjustments | ONR | French women with breast cancer | 14 | 126 days | Multi | Yes | Note that toxic effects were sufficiently bad at 8 g per day that they stopped dose escalation at that point; 6 g per day was the maximum safe dose | ||||||||||||||||
99 | Docetaxel | Curcumin (6,000 mg qd for 4 days before and 2 days after drug infusion) | Improved short-term clinical outcomes (improved PSA levels) | Mahammedi 2016 | Beneficial to combine | ONR | French men with progressive, castration-resistant prostate cancer | 30 | 126 days | Multi | No | |||||||||||||||||
100 | Docetaxel | Echinacea purpurea aerial parts 95% and root 5% tincture (20 drops tid) | No change in pharmacokinetics or side effects of doceetaxel | Goey 2013 | Fine to combine without dose adjustments | ONR | Dutch adults with cancer | 10 | 21 days | Single | Yes | A. Vogel Echinaforce, Biohorma BV, Elburg, the Netherlands | Docetaxel is normally given as a single intravenous dose once every three weeks so this study's methodology was fairly sound though it was a single dose trial. |